SCHEMBL27968907

SCHEMBL27968907

CCOC(=O)c1cc2c(n1F)CCCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
MAPK1 P28482 6/20 0.47
MAPT P10636 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 4/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALOX15 P16050 2/20 0.46
KDM4E B2RXH2 7/20 0.43
GAA P10253 4/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TP53 P04637 2/20 0.41
GLA P06280 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9100639 0.84 MAPK1 (0.45) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL12777541 0.82 MAPK1 (0.44) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL12777540 0.82 ALDH1A1 (0.47) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL28812869 0.80 KDM4E (0.40) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL1393341 0.78 ALDH1A1 (0.44) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL1392959 0.77 ALDH1A1 (0.43) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL27968905 0.77 ADORA3 (0.39) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL24374892 0.76 ALDH1A1 (0.40) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL14916940 0.76 ALDH1A1 (0.42) ALDH1A1MAPK1MAPTMEN1KMT2A
SCHEMBL14925991 0.75 ALDH1A1 (0.42) ALDH1A1MAPK1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104024255-A Alkylated piperazine compounds as inhibitors of BTK activity HOFFMANN LA ROCHE 2014-09-03 CN disclosed